免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

日立Supria全身X光CT系統第3階段

K 號:K163528 · 2017-03-03

決定日期2017-03-03
產品代碼JAK
諮詢委員會RA
決定相當於

器材摘要

HITACHI Supria Whole-body X-ray CT System Phase 3 is the device name listed in this FDA 510(k) record. The listed applicant is Hitachi Medical Systems America, Inc.. It received FDA 510(k) clearance on 2017-03-03 under 510(k) number K163528. The device is classified under product code JAK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the HITACHI Supria Whole-body X-ray CT System Phase 3?

HITACHI Supria Whole-body X-ray CT System Phase 3 is a medical device that received FDA 510(k) clearance on 2017-03-03. The listed applicant is Hitachi Medical Systems America, Inc.. The 510(k) number is K163528.

When did HITACHI Supria Whole-body X-ray CT System Phase 3 receive FDA 510(k) clearance?

HITACHI Supria Whole-body X-ray CT System Phase 3 received FDA 510(k) clearance on 2017-03-03, under 510(k) number K163528.

Who is the listed applicant for HITACHI Supria Whole-body X-ray CT System Phase 3?

The FDA 510(k) record lists Hitachi Medical Systems America, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for HITACHI Supria Whole-body X-ray CT System Phase 3?

The FDA product code for HITACHI Supria Whole-body X-ray CT System Phase 3 is JAK.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Hitachi Medical Systems America, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:JAK)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑